Agios Pharmaceuticals Inc (AGIO)

Cash & Equivalents

$99.65M

Quarterly · Period ending: · USD

AGIO logo

AGIO Cash & Equivalents

Latest reported$99.65M
AGIO Quarterly Cash & Equivalents ($91.30M → $99.65M)
High-resolution chart · PNG

AGIO cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Agios Pharmaceuticals Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
99,647,000
113,600,000
89,130,000
92,710,000
80,871,000
78,964,000
76,247,000
253,730,000
84,518,000
118,764,000
88,205,000
64,333,000
84,753,000
104,139,000
139,259,000
122,449,000
88,543,000
80,026,000
203,126,000
400,224,000
969,124,000
1,888,025,000
127,436,000
104,855,000
295,858,000
89,093,000
80,931,000
81,709,000
83,580,000
103,443,000
805,421,000
156,478,000
210,323,000
994,747,000
567,750,000
132,741,000
138,717,000
200,278,000
573,564,000
285,502,000
512,295,000
355,754,000
375,907,000
407,986,000
434,037,000
439,964,000
14,031,000
70,049,000
108,247,000
32,837,000
71,560,000
106,011,000
77,481,000
83,377,000
91,297,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.